Keywords: tlc, files, evacet, breast, cancer, usa, liposome

TLC files Evacet for breast cancer in USA

Article | 24 February 1999

Print This

The Liposome Company has filed for approval to market its liposomalformulation of doxorubicin, Evacet, in the USA for the first-line ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in